Surface Oncology Inc (SURF) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering SURF.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
SURF Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- Surface Oncology Inc's percent of analysts bearish on the stock is lower than almost 100% of all US stocks.
- The percentage of analysts bullish on the stock of SURF is greater than 82.11% of all US stocks.
- The upside potential (average analyst target price relative to current price) of SURF is greater than 78.4% of all US stocks.
- The variance in analysts' estimates of SURF is lower than 22.84% of stocks in the small market cap category.
- The average analyst price target of SURF is greater than 27.73% of all US stocks.
- The number of analysts covering the stock of SURF is greater than 67.32% of stocks in the small market cap category.
- SURF has a less change in bullishness amongst analysts than almost 100% of all US stocks.
Is SURF a Buy, Hold or Sell? See the POWR Ratings now!